Reuters logo
BRIEF-Protein Sciences reports good safety results from lead zika vaccine in preclinical studies
January 12, 2017 / 3:29 PM / 10 months ago

BRIEF-Protein Sciences reports good safety results from lead zika vaccine in preclinical studies

Jan 12 (Reuters) - Protein Sciences Corporation:

* Lead zika vaccine candidate had good safety results, induced strong neutralizing antibodies against zika virus in preclinical studies

* Zika vaccine is expected to advance into human clinical trials in next few months

* In preclinical testing, purified protein formulated with alum induced strong levels of neutralizing antibodies in outbred mice

* Says preparations are being made to start a phase I clinical study in United States in April 2017

* Vaccine candidate demonstrated good safety data in sponsored toxicology study Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below